DEXCOM INC
Develops continuous glucose monitoring (CGM) systems for diabetes management.
DXCM | US
Overview
Corporate Details
- ISIN(s):
- US2521311074
- LEI:
- Country:
- United States of America
- Address:
- 6340 SEQUENCE DRIVE, 92121 SAN DIEGO
- Website:
- https://www.dexcom.com/
- Sector:
- Manufacturing
Description
Dexcom Inc. is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems for diabetes management. The company's core technology consists of wearable sensors that continuously measure and transmit glucose levels to a compatible smart device or receiver, providing real-time data, alerts, and trend information. Its product portfolio, which includes the Dexcom G6, G7, and the over-the-counter Stelo Glucose Biosensor System, is designed to help people with diabetes make treatment decisions without traditional fingersticks. The systems also assist users in understanding how lifestyle factors like diet and exercise impact their glucose levels, empowering them to take greater control of their health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all DEXCOM INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DEXCOM INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DEXCOM INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
